Clinical outcomes in patients with adamantinoma: Report from the bone and soft tissue tumor registry in Japan.
J Surg Oncol
; 129(5): 1000-1005, 2024 Apr.
Article
em En
| MEDLINE
| ID: mdl-38263585
ABSTRACT
BACKGROUND:
Adamantinomas are rare malignant bone tumors. Due to their low incidence, there are few reports on the clinical results of adamantinoma.OBJECTIVES:
This study aims to clarify outcomes in patients with adamantinoma using data from the National Bone and Soft Tissue Tumor Registry.METHODS:
From 2006 to 2019, 38 cases of tibial origin were included. Twenty-four were male and 14 were female, with a mean age of 37 (6-87) years and a mean follow-up of 35 (1-128) months.RESULTS:
Surgery was performed in 33 cases (87%) (curettage 4 cases, wide resection 27 cases, amputation 2 cases). Reconstruction was performed in 27 patients who underwent wide resection. A total of 12 additional surgeries were performed in 11 patients. The main reason for the additional surgeries was nonunion of grafting bone in 6 cases. Oncologic outcomes were DOC (death from other causes) in one case and NED (no evidence of disease) in 37 cases.CONCLUSIONS:
The results of treatment of adamantinomas in Japan have been extremely favorable. This may be due in part to the large number of cases with wide resection.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Ósseas
/
Adamantinoma
Limite:
Adult
/
Female
/
Humans
/
Male
País como assunto:
Asia
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article